Global Muscle Relaxants Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2017 – 2025

TABLE OF CONTENTS

Chapter 1        Prefix

1.1    Market Scope

1.2    Report Description

1.3    Research Methodology

1.3.1     Primary Research

1.3.2     Secondary Research

1.3.3     In-house Data Modeling

Chapter 2        Executive Summary

2.1   Global Muscle Relaxants Market Year-on-Year Growth, 2020 – 2028 (%)

Chapter 3        Market Outline

3.1    Market Inclination, Trend, Outlook and Viewpoint

3.2    Market Share Analysis: Company’s Competitive Scenario

3.3    Value Chain Analysis

3.4    Porter’s Five Forces Analysis

3.5    Market Dynamics

3.5.1     Drivers

3.5.1.1     Impact Analysis

3.5.2     Restraints

3.5.2.1     Impact Analysis

3.5.3     Opportunities

Chapter 4        Global Muscle Relaxants Market by Drug Type: Market Size and Forecast, 2019 – 2028

4.1    Overview

4.2  Facial Aesthetic Relaxant Drugs

4.2.1   Current Trend and Analysis

4.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.3  Skeletal Muscle Relaxant Drugs

4.3.1   Current Trend and Analysis

4.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.3.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.4  Neuromascular Blocking Agents

4.4.1   Current Trend and Analysis

4.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.4.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 5        Global Muscle Relaxants Market by Geography: Market Size and Forecast, 2019 - 2028

5.1  Overview

5.1.1   Global Muscle Relaxants Market Year-on-Year Growth, by region 2020 – 2028 (%)

5.2  North America

5.2.1   Current Trend and Analysis

5.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.2.3   U.S.

5.2.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

5.2.3.2        By Drug Type

5.2.4   Canada

5.2.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

5.2.4.2        By Drug Type

5.2.5   Mexico

5.2.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

5.2.5.2        By Drug Type

5.3    Europe

5.3.1   Current Trend and Analysis

5.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.3.3   UK

5.3.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

5.3.3.2        By Drug Type

5.3.4   Russia

5.3.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

5.3.4.2        By Drug Type

5.3.5   France

5.3.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

5.3.5.2        By Drug Type

5.3.6   Italy

5.3.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

5.3.6.2        By Drug Type

5.3.7   Germany

5.3.7.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

5.3.7.2        By Drug Type

5.3.8   Rest of Europe

5.3.8.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

5.3.8.2        By Drug Type

5.4    Asia-Pacific

5.4.1   Current Trend and Analysis

5.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.4.3   China

5.4.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

5.4.3.2        By Drug Type

5.4.4   India

5.4.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

5.4.4.2        By Drug Type

5.4.5   Japan

5.4.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

5.4.5.2        By Drug Type

5.4.6   Rest of Asia-Pacific

5.4.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

5.4.6.2        By Drug Type

5.5    RoW

5.5.1   Current Trend and Analysis

5.5.2   Market Size and Forecast

5.5.3   South America

5.5.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

5.5.3.2        By Drug Type

5.5.4   Middle East

5.5.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

5.5.4.2        By Drug Type

5.5.5   Africa

5.5.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

5.5.5.2        By Drug Type

Chapter 6        Company Profiles

6.1  Hoffmann-LA Roche Ltd.

6.1.1     Company Overview

6.1.2     Product Portfolio

6.1.3     Business Strategies

6.1.4     Financials

6.1.5     Recent Developments

6.2  Johnson & Johnson

6.2.1     Company Overview

6.2.2     Product Portfolio

6.2.3     Business Strategies

6.2.4     Financials

6.2.5     Recent Developments

6.3  GlaxoSmithKline

6.3.1     Company Overview

6.3.2     Product Portfolio

6.3.3     Business Strategies

6.3.4     Financials

6.3.5     Recent Developments

6.4  Intas Pharmaceuticals Ltd.

6.4.1     Company Overview

6.4.2     Product Portfolio

6.4.3     Business Strategies

6.4.4     Financials

6.4.5     Recent Developments

6.5  Pfizer Inc.

6.5.1     Company Overview

6.5.2     Product Portfolio

6.5.3     Business Strategies

6.5.4     Financials

6.5.5     Recent Developments

6.6  Galderma S.A.

6.6.1     Company Overview

6.6.2     Product Portfolio

6.6.3     Business Strategies

6.6.4     Financials

6.6.5     Recent Developments

6.7  Merck & Co, Inc.

6.7.1     Company Overview

6.7.2     Product Portfolio

6.7.3     Business Strategies

6.7.4     Financials

6.7.5     Recent Developments